People · Operator
Named in public records as an officer, director or promoter · active 2018–2024 · Other Health Care, Biotechnology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ArcherDX, Inc. | — | Other Health Care | Series C | $115.1M | $35.6M | 2018 |
| Genapsys, Inc. | — | Biotechnology | Series B | $106.0M | $871.9M | 2021 |
| TwinStrand Biosciences, Inc. | — | Biotech / Pharma | Series C | $85.0M | $132.4M | 2023 |
| Switchback Systems, Inc. | — | Biotechnology | Series A | $18.1M | $57.8M | 2024 |
Jason Myers at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jason Myers on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| PAUL CONLEY | 1 | 17 |
| Chad Waite | 1 | 11 |
| Kyle Lefkoff | 1 | 9 |
| Craig Asher | 1 | 8 |
| Steve Dow | 1 | 7 |
| Paul B. Manning | 1 | 6 |
| Paul Manning | 1 | 6 |
| Robert Zollars | 1 | 5 |
| Soma Somasegar | 1 | 5 |
| Michael Pellini | 1 | 4 |
| A Craig Asher | 1 | 4 |
| Mike Pellini | 1 | 3 |
| Frank Witney | 1 | 3 |
| Jesse Salk | 1 | 3 |
| Christopher Benoit | 1 | 3 |
| Fred F. Nazem | 1 | 2 |
| Todd Druley | 1 | 2 |
| Marvin H Caruthers | 1 | 2 |
| Linden Rhoads | 1 | 2 |
| Marvin Caruthers | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.